Misr pharma R&D centre
Misr Pharma is continuously building its R&D capabilities with aim of participating in building an R&D culture in the Middle East.
It’s a state-of-the-art, custom-designed R&D with all of the resources necessary to take pharmaceutical research programs from “Lab bench to the Pre-clinic.” — from initial development to start bio-equivalence. The R&D is well equipped with various ultramodern equipments and technologies required for conducting high quality research activities and prototype equipments as that of manufacturing facilities.
Currently, R&D facility boasted a team of professionals, all of which are scientists with specialist skills in various pharmaceutical disciplines i.e. formulation development, feasibility studies, formulation screening to clinical trial material manufacturing, analytical development, release testing, ICH stability testing and up to full-scale CGMP production of finished solid dosage form products.These professionals are well trained to conduct R&D activities, which involve basic pharmaceutical technologies and analysis for all oral, ocular & topical dosage forms and the highly specific niche technologies based platforms that include slow-release and modified release products.
R&D team has succeeded in developing products from a broad list of categories including product line extension, generic drugs, over-the-counter and disinfectants products as well as patent non-infringing formulations that enables getting MAs before patent expiry. It is deliberately ensured that our development manufacturing technology of lab & pilot batch size is scalable to commercial processes to provide a smooth transition into market volumes.
Our in-licensing clients include leading pharmaceutical companies, Abbott, Louis Widmer, Merck, Janssen, smith & nephew, Meda, Mylan and Norgine etc.